2005
DOI: 10.1093/annonc/mdi142
|View full text |Cite
|
Sign up to set email alerts
|

Liver does not care about age

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2007
2007
2025
2025

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…With respect to this, Turrini et al [22] compared the evolution of two groups of patients aged between 70 and 80 years, all of them with less than four resectable metachronous LM. The first group consisted of 15 patients treated by hepatectomies and without neoadjuvant chemotherapy to avoid deterioration in liver function.…”
Section: Discussionmentioning
confidence: 99%
“…With respect to this, Turrini et al [22] compared the evolution of two groups of patients aged between 70 and 80 years, all of them with less than four resectable metachronous LM. The first group consisted of 15 patients treated by hepatectomies and without neoadjuvant chemotherapy to avoid deterioration in liver function.…”
Section: Discussionmentioning
confidence: 99%
“…Older patients may be discriminated against on the basis of higher risk benefit ratio, protracted recovery to pre‐morbid state and presumed higher morbidity and mortality rates. A number of authors have published the results of hepatic resection in selected older patients with variable age groups . Although most published studies show equivalence in outcomes between older and younger patients, there is a bias towards lower volumes of disease, lesser resections and less preoperative chemotherapy.…”
Section: Introductionmentioning
confidence: 99%
“…A number of authors have published the results of hepatic resection in selected older patients with variable age groups. [9][10][11][12][13][14][15][16][17] Although most published studies show equivalence in outcomes between older and younger patients, there is a bias towards lower volumes of disease, lesser resections and less preoperative chemotherapy. We have chosen a cut of age of 75 for our cohort of older patients in line with the increased age of the ANBCSP, to assess whether aggressive curative-intent treatment of metastases in these patients is acceptable.…”
Section: Introductionmentioning
confidence: 99%